Karuppiah Kannan
Inventor
Stats
- 1 US patents issued
- 9 US Applications filed
- most recent filing
This is official USPTO record data
Details
- 1 US Patents Issued
- 9 US Applications Filed
- 7 Total Citation Count
- Jun 1, 2020 Most Recent Filing
- Aug 27, 2004 Earliest Filing
Work History
Patent Owner | Applications Filed | Year |
---|---|---|
AVEO PHARMACEUTICALS, INC. | 1
2 2 | 2004
2005 2006 |
FORMULATION TECHNOLOGIES, LLC DBA PHARMAFORM | 1
| 2015
|
ARCHIMEDES DEVELOPMENT LIMITED | 1
| 2004
|
MILLENNIUM PHARMACEUTICALS, INC. | 3
| 2015
|
Inventor Addresses
Address | Duration |
---|---|
Cambridge, MA | Oct 05, 06 - Feb 22, 07 |
Cambridge, MA, US | Jul 07, 09 - Jul 07, 09 |
Newton, MA, US | Feb 09, 17 - Oct 08, 20 |
Technology Profile
Technology | Matters | |
---|---|---|
A61K: | PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES | 9 |
A61P: | THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS | 3 |
C07H: | SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS | 1 |
Patents / Publication
Patents / Publication # | Year of Publication / Issued | Title | Citations |
---|---|---|---|
2020/0316,067 | 2020 | COMBINATION OF RAF INHIBITORS AND TAXANES | 0 |
10426782 | 2019 | Pharmaceutical formulations of a pan-RAF kinase inhibitor and processes for their preparation | 0 |
2019/0231,757 | 2019 | COMBINATION OF SPLEEN TYROSINE KINASE INHIBITORS AND OTHER THERAPEUTIC AGENTS | 0 |
2019/0117,652 | 2019 | COMBINATION OF RAF INHIBITORS AND TAXANES | 0 |
2018/0066,068 | 2018 | ANTI-PSYK ANTIBODY MOLECULES AND USE OF SAME FOR SYK-TARGETED THERAPY | 0 |
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level.
>
Upgrade to our Level for up to -1 portfolios!.